Subscribe
georgeclerk
GeorgeClerk / iStockphoto.com
10 October 2017Big PharmaRachel Bradley

After Brexit: new directions for clinical trials

A new regime for clinical trials in Europe is coming into force in 2018. However, there are uncertainties about what clinical trials legislation will apply in the UK once it leaves the EU. This article is a brief summary of the changes that will come into force for businesses based in Europe and for global businesses running clinical trials in Europe, and the potential impact of Brexit.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
What 2020 means for the life sciences
15 December 2020   Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
Big Pharma
Life sciences industry calls for Brexit transition period
29 November 2017   The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.
Big Pharma
EMA voices ‘serious concerns’ over MA holders’ Brexit preparedness
11 July 2018   The European Medicines Agency has expressed concerns about how prepared medical marketing authorisation holders are for when the UK leaves the EU.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Big Pharma
What 2020 means for the life sciences
15 December 2020   Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
Big Pharma
Life sciences industry calls for Brexit transition period
29 November 2017   The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.
Big Pharma
EMA voices ‘serious concerns’ over MA holders’ Brexit preparedness
11 July 2018   The European Medicines Agency has expressed concerns about how prepared medical marketing authorisation holders are for when the UK leaves the EU.

More on this story

Big Pharma
What 2020 means for the life sciences
15 December 2020   Between Brexit and COVID-19, 2020 has had seismic implications for the life sciences industries. Sally Shorthose and Rumana Khanom of Bird & Bird report.
Big Pharma
Life sciences industry calls for Brexit transition period
29 November 2017   The EU and UK must make progress in Brexit negotiations “as soon as possible”, according to the associations that represent the European and British life sciences industry.
Big Pharma
EMA voices ‘serious concerns’ over MA holders’ Brexit preparedness
11 July 2018   The European Medicines Agency has expressed concerns about how prepared medical marketing authorisation holders are for when the UK leaves the EU.

More features

Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
‘Don’t stifle UK AI innovation’: King's speech on AI Act prompts warnings
Novo Nordisk’s uphill battle in the counterfeit weight loss craze
FTC supports USPTO terminal disclaimer plan amid opposition
Labour govt appoints new Minister with IP oversight